Company: HURA
Filing Date: 2025-02-07
Form Type: S-4
Source: 0001193125-25-022803
Chunk: 835

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-02-07
Form: S-4
Chunk 835
---
 common stock to investors in the Private Placement, each at an exercise price of $0.14, with exercise contingent upon the Merger closing and exercisable following the first closing of the Private Placement. These warrants were subsequently cancelled in December 2022 upon amendment of the Securities Purchase Agreement.

In December 2022, the Company issued 121,000 warrants to purchase shares of its common stock to existing stockholders, each at an exercise price of $0.14, with exercise contingent upon the Merger closing. The Company determined that the contingent exercise provision was indexed to the Company’s operations and the warrants qualified for equity classification. As the warrants issued to the certain existing stockholders results in value being transferred, the Company recorded warrant expense of $3.3 million within other income and (expense) on the statement of operations.

In December 2022, the Company issued 104,000 warrants to purchase shares of its common stock in connection with the Private Placement (see below).

Upon completion of the Merger in December 2022, the Company issued 14,000 warrants to purchase shares of its common stock to former Yumanity warrant holders.

<div align='center'>F-107</div>

KINETA, INC. Notes to Consolidated Financial Statements During the year ended December 31, 2022, the Company issued 53,000 shares of its common stock upon exercise of warrants and received proceeds of $71,000. The exercise price of all shares exercised during the year ended December 31, 2022 ranged from $0.14 to $26.88. Common Stock Upon completion of the Merger in December 2022, the number of authorized shares of common stock of the Company was adjusted to 125,000,000 with a par value of $0.001 and all non-votingshares became voting shares. As of December 31, 2023, there were 10,396,614 shares issued and outstanding. Common stock reserved for future issuance consisted of the following as the period presented:

|                                                                                                                    |     | December 31,  
 2023          |       |
|:-------------------------------------------------------------------------------------------------------------------|:----|:--------------|------:|
|                                                                                                                    |     | -in thousands |       |
| Shares reserved for stock options and restricted stock units to purchase common stock under equity incentive plans |     |               | 1,983 |
| Shares reserved for future issuance of equity awards                                                               |     |               |   932 |
| Shares reserved for